{"metadata":{"topics":["Acceleration","Accountability","Administrative law","Anniversary","Applied ethics","Bad debt","Behavioural sciences","Belgium","Board of directors","Business","Business economics","Business law","Business organizations","By-law","California","Cash","Chargeback","Chief executive officer","Civil law (common law)","Civil law (legal system)","Clinical trial","Common law","Common stock","Companies","Company","Comparative law","Consent","Constitutional law","Contract","Contract law","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporations","Court","Culture","Debt","Definition","Demographic economics","Derivatives (finance)","Drug","Economic law","Economics","Economics of service industries","Economies","Economy","Economy of the United States","Employee handbook","Employee relations","Employment","Employment compensation","Energy","Equity securities","Ethical principles","Europe","Executive branch of the United States government","Executive compensation","Exercise","Expanded access","Expense","Factor income distribution","Fair market value","Family economics","Federal judiciary of the United States","Fidaxomicin","Finance","Financial accounting","Financial economics","Financial law","Financial markets","Financial services","Financial statements","Fiscal year","Food","Food and Drug Administration","Fraction (mathematics)","France","Germany","Governance","Government","Government agencies","Government finances","Government information","Government institutions","Government of the United States","Health","Health care","Health economics","Health insurance","Health policy","Health sciences","Healthcare","Healthcare industry","Household income","Human activities","Incentive","Income","Income statement","Industries","Information","Insurance","Intellectual works","Interest","Interpersonal relationships","Investment","Invoice","Italy","Jargon","Judiciaries","Jurisdiction","Justice","Labor","Labour law","Labour relations","Law","Law and economics","Law of obligations","Lawsuit","Leadership","Legal concepts","Legal documents","Legal fictions","Legal writing","Liability (financial accounting)","License","Life sciences","Managed care","Management","Market (economics)","Market value","Marketing","Medication","Medicine","Microeconomics","Money","Morality","Natural resources law","New Drug Application","North America","Number","Official documents","Optimer Pharmaceuticals","Option (finance)","Options (finance)","Patient","Payment","Payments","Payroll","Percentage","Personal finance","Personal jurisdiction","Pharmaceutical industry","Pharmaceutical sciences","Pharmacology","Pharmacy","Pharmacy benefit management","Philosophical theories","Political economy","Political science","Politics","Politics of the United States","Poverty","Price","Private law","Pro rata","Programs","Property","Property law","Protectionism","Public administration","Public finance","Public law","Public policy","Public sector","Public services","Public sphere","Quantity","Remainder","Restricted stock","Revenue","Right-to-work law","Rules","Salary","Sales","San Diego","Securities (finance)","Service industries","Services (economics)","Share (finance)","Sick leave","Signing bonus","Social institutions","Social issues","Social policy","Social programs","Sociological theories","Spain","Standard deduction","Stock","Stock market","Sweden","Tax","Tax deduction","Tax refund","Taxation","Trade","Transport","United Kingdom","United States","United States dollar","United States economic policy","United States federal policy","United States law","Urban, rural, and regional economics","Vacation","Value (ethics)","Value added","Vesting","Virtue","Wages and salaries","Wealth","Welfare state","Withholding tax","Working conditions","Working time","Write-off"],"person_names":["michael n. chang","pedro lichtinger"],"vars":{},"organization_names":["change of control","inc.","optimer pharmaceuticals","standard vesting"],"agreement_id":"276903d65c66d1b314244f97c578b9ac1110a2e7abb5f9a776a02a160d6bdcb4","terms":["**Exhibit A**","’s Severance Benefit Plan (the “Severance Plan”","“Additional Term”","“Board”","“Company”","“Equity Incentive Plan”","“Initial Option”","“Initial Term”","“RSUs”","“Start Date”"]}}